Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult ...
An ejection fraction of 55% or more is considered normal ... SGLT2 inhibitors may also be recommended, as they've been shown to reduce the risk of cardiovascular death and hospitalization for heart ...
Although an ejection fraction below 55% is abnormal, an ejection fraction ≤40% is considered heart failure with reduced ejection fraction (HFrEF), also known as systolic heart failure. A low EF can ...
Importantly, we observed IGF-1 showed significant lower levels in patients with reduced ejection fraction (HFrEF) compared to the controls, not in patients with preserved ejection fraction (HFpEF).
This is unlike heart failure with reduced ejection fraction (HFrEF), where the heart muscle is weakened and unable to pump with enough force—therefore, less blood is being pushed into the body.